Form 4: Director Receives Restricted Stock Grant

Lisa Egbuonu-Davis, a Director at Omega Healthcare Investors Inc., was granted restricted stock valued at $43.67 per share.

Summary

• Lisa Egbuonu-Davis, a Director of Omega Healthcare Investors Inc., received a restricted stock grant on June 5, 2026.
• The grant consists of 3,778 shares of common stock.
• The value of the grant is based on a price of $43.67 per share.
• These shares will vest on the date of the Company's 2027 Annual Meeting of Shareholders, approximately one year from the grant date.
• The restricted stock will convert to common stock on a one-for-one basis upon vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation and does not contain new financial performance data or strategic shifts.

Positives

• Director compensation awarded in the form of restricted stock, aligning director interests with shareholder value.
• The grant is a form of incentive compensation for the director.
• The value of the restricted stock is clearly defined at $43.67 per share.

Risks

• The value of the restricted stock is subject to market fluctuations until vesting.
• Vesting is contingent on the director remaining in their role until the 2027 Annual Meeting of Shareholders.

Future Outlook

The restricted stock granted will vest approximately one year from the grant date, on the date of the Company's 2027 Annual Meeting of Shareholders, at which point it will convert to common stock.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock to directors is a common practice in the healthcare REIT sector to incentivize long-term commitment and align executive interests with those of shareholders, particularly in a company like Omega Healthcare Investors which operates in a capital-intensive industry.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns director incentives with long-term shareholder value creation.
• Director Egbuonu-Davis: Receives compensation in the form of equity, subject to vesting conditions.

Next Steps

• Vesting of restricted stock on the date of the Company's 2027 Annual Meeting of Shareholders.
• Conversion of vested restricted stock to common stock on a one-for-one basis.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Director Compensation, Restricted Stock, Omega Healthcare Investors, OHI, Stock Grant, Beneficial Ownership